Natalie Schub
University Hospital Schleswig-Holstein(DE)University of Lübeck(DE)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Protein Degradation and Inhibitors, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial(2020)79 cited
- → Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective(2010)71 cited
- → Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma(2024)70 cited
- → Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients(2008)63 cited
- → Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities(2024)38 cited
- → Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial(2024)36 cited